Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DENA17
|
|||
| Drug Name |
CD24Fc
|
|||
| Synonyms |
MK 7110
Click to Show/Hide
|
|||
| Drug Type |
Recombinant protein
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 3 | [1] | |
| Company |
OncoImmune
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04317040) CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment (SAC-COVID). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.